Please provide your email address to receive an email when new articles are posted on . The multinational program has delivered 2 billion doses of COVID-19 vaccines to 146 nations and saved 2.7 ...

In an August 2021 press conference, Mike Ryan, the director of the World Health Organization’s (WHO) Health Emergencies Program, likened COVID-19 vaccinations to life vests one straps on in a sinking ...

The Microsoft mogul’s vaunted charity has done more harm than good, according to this heated polemic. Journalist Schwab debuts with an exploration of the allegedly counterproductive machinations of ...

Covid-19 Vaccines handed over under the COVAX programme with Team Europe represented by the countries Austria, Czech Republic, Frannce, Greece and Italy at Ministry of Health and Population, Ram Shah ...

The board of Gavi, the international vaccine agency, meets Wednesday to debate shutting down the program, known as Covax, amid swiftly waning demand for the shots. By Stephanie Nolen Stephanie Nolen, ...

The United Nations-backed COVAX vaccine program will send 10 million doses of Pfizer/BioNTech COVID-19 shots for children to Mexico by the end of September, a senior Mexican official announced Tuesday ...

MEXICO CITY (Reuters) - The United Nations-backed COVAX vaccine program has offered Mexico 10 million doses of Pfizer/BioNTech COVID-19 shots for children after the country's president vowed to ...

U.S. vaccine maker Novavax slumped nearly 31% on Tuesday as falling demand for its COVID-19 shot from low- and middle-income nations led the company to cut its annual revenue expectation by half.

Novavax (NVAX) missed Wall Street expectations Monday after its second quarter earnings showed softer-than-expected demand in global vaccine sales, forcing the company to slash its 2022 outlook by 50% ...

Aug 3 (Reuters) - Moderna Inc (MRNA.O), opens new tab on Wednesday maintained its full-year COVID-19 vaccine sales forecast of $21 billion as canceled orders from low- and middle-income nations ...

Moderna Inc on Wednesday maintained its full-year COVID-19 vaccine sales forecast of $21 billion as canceled orders from low- and middle-income nations through the COVAX program offset gains from new ...